Cardiovascular Diseases Research in Oregon
Cardiovascular Diseases Research (93.837) awarded $129 million to recipients in Oregon in 116 grants from fiscal 2021 to 2025, 0.9% of the program's national total. Oregon Health & Science University received the most, $99.0 million.
- Awarded in Oregon$129 million
- Awards116
- Share of the program0.9%
- Rank among states26th of 51
- National total$15 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 54 | $21.7 million |
| FY 2022 | 55 | $21.8 million |
| FY 2023 | 56 | $24.5 million |
| FY 2024 | 56 | $28.4 million |
| FY 2025 | 59 | $32.1 million |
Recipients in Oregon
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| Oregon Health & Science University | Colleges and universities | 89 | $99.0 million |
| Aronora Inc | Small businesses | 5 | $12.0 million |
| University of Oregon | Colleges and universities | 8 | $5.3 million |
| Hemex Health Inc | Small businesses | 3 | $3.5 million |
| Oregon State University | Colleges and universities | 2 | $3.5 million |
| Narnar, Inc. | Small businesses | 2 | $2.2 million |
| Ochin, Inc | Nonprofits | 1 | $673,581 |
| Exhalix, LLC | Small businesses | 1 | $500,000 |
| Elex Biotech, Inc | Small businesses | 1 | $471,323 |
| Lazarus 3D, Inc | Small businesses | 1 | $400,016 |
Open opportunities under this program
- Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)
- Emerging Global Leader Award (K43 Independent Clinical Trial Required)
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)
- NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)
- Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)
- NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
See all 82 on the program page
Questions people ask
How much Cardiovascular Diseases Research money goes to Oregon?
$129 million from fiscal 2021 to 2025, across 116 awards. Oregon ranks 26th of 51 states and territories for this program.
Who receives Cardiovascular Diseases Research money in Oregon?
The largest recipient is Oregon Health & Science University, with $99.0 million in 89 awards. Next are Aronora Inc and University of Oregon.
Can organizations in Oregon apply now?
Yes, 82 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cardiovascular Diseases Research in other states
Other large programs in Oregon
- Grants to States for Medicaid
- Highway Planning and Construction
- Children's Health Insurance Program
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- Education Stabilization Fund
- National School Lunch Program
- Federal Transit Formula Grants
- Head Start
- Temporary Assistance for Needy Families
- Child Care and Development Block Grant